ADHESION MOLECULE TARGETED THERAPY FOR NON-INFECTIOUS UVEITIS
CD4+ T-Cell Plasticity in Non-Infectious Retinal Inflammatory Disease
Small-molecule antagonist of VLA-4 (GW559090) attenuated neuro-inflammation by targeting Th17 cell trafficking across the blood-retinal barrier in experimental autoimmune uveitis.
Leukotriene B4 and Its Receptor in Experimental Autoimmune Uveitis and in Human Retinal Tissues: Clinical Severity and LTB4 Dependence of Retinal Th17 Cells.
Prospective study of morphologic and functional parameter changes post intravitreal therapy for macular edema.
Functionally Distinct Th17/Th1 (IFNγ+IL-17A+) cells in experimental autoimmune uveitis (EAU): T cell heterogeneity, plasticity and steroid response.
